The company did say they were looking to enrol up to 300 patients for the study. Agree that the trials weren't as comprehensive as they should be. $15 million sounds about right. Agree not all the money needed could be raised in one placement. Let's see what they can do from here on. I still reckon it's worth a punt. Market cap is still small and the capital structure is still very attractive.
worth a punt, page-20
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.27M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.7¢ | $209.6K | 26.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 21920406 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 6056633 | 6 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |